News

                                                        Contact:

Merle Spiegel

(203) 588-8050

FOR IMMEDIATE RELEASE

Purdue Pharma Launches the Purdue Pharma Fund to Focus Contributions on Pain Management

Initial $3 Million Grant to Massachusetts General Hospital Will Make Possible
Expanded, State-of-the-Art Pain Education, Treatment, and Research Center

Stamford, CT – February 5, 2002 – Purdue Pharma L.P. has restructured its charitable contributions program to create a new vehicle dedicated to the field of pain management. The Purdue Pharma Fund will focus the company’s contributions on nonprofit organizations dealing with education, treatment, and research involving patients with pain. Kicking off this new Fund is a $3 million pledge to Massachusetts General Hospital to create the MGH Purdue Pharma Pain Center, a state-of-the-art facility dedicated to treating people suffering from chronic pain and educating healthcare professionals about the tools and techniques available for such treatment.

“This year marks Purdue Pharma’s 50th anniversary, and this major commitment to Mass General is one of the ways we have chosen to celebrate that milestone,” said Michael Friedman, Executive Vice President and Chief Operating Officer. “We are delighted to be partnering with such a highly recognized institution on a range of educational efforts that will improve the understanding and management of pain for generations to come.”

In addition to those organizations focusing on pain, the Purdue Pharma Fund will benefit a wide array of organizations in the medical education arena and enhance the quality of life in the various communities where Purdue operates. Last year, the company invested more than $4 million in educational and civic organizations including the American Pain Foundation, American Alliance of Cancer Pain Initiatives, Tufts University School of Medicine, Community Anti-Drug Coalitions of America, National Center on Addiction and Substance Abuse at Columbia University, and CURE (Connecticut United for Research Excellence).

Purdue Pharma L.P., headquartered in Stamford, CT, is a privately held pharmaceutical company known for its pioneering research on chronic pain. The company is engaged in the research, development, production and distribution of both prescription and over-the-counter medicines and hospital products. Additional information about Purdue can be found at www.purduepharma.com.